nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—ADRB1—coronary artery disease	0.134	0.543	CbGaD
Labetalol—ADRB2—coronary artery disease	0.113	0.457	CbGaD
Labetalol—ADRB3—Timolol—coronary artery disease	0.0765	0.278	CbGbCtD
Labetalol—ADRB2—Penbutolol—coronary artery disease	0.0444	0.161	CbGbCtD
Labetalol—ADRB1—Penbutolol—coronary artery disease	0.0437	0.159	CbGbCtD
Labetalol—Salicylamide—Acetylsalicylic acid—coronary artery disease	0.0424	0.132	CrCrCtD
Labetalol—Quinapril—Perindopril—coronary artery disease	0.0359	0.112	CrCrCtD
Labetalol—ADRB2—Timolol—coronary artery disease	0.0313	0.114	CbGbCtD
Labetalol—ADRB1—Timolol—coronary artery disease	0.0308	0.112	CbGbCtD
Labetalol—Quinapril—Trandolapril—coronary artery disease	0.028	0.0872	CrCrCtD
Labetalol—Quinapril—Enalapril—coronary artery disease	0.028	0.0872	CrCrCtD
Labetalol—Benazepril—Trandolapril—coronary artery disease	0.0267	0.083	CrCrCtD
Labetalol—Benazepril—Enalapril—coronary artery disease	0.0267	0.083	CrCrCtD
Labetalol—Lisdexamfetamine—Lisinopril—coronary artery disease	0.0259	0.0805	CrCrCtD
Labetalol—Salsalate—Acetylsalicylic acid—coronary artery disease	0.0236	0.0735	CrCrCtD
Labetalol—Quinapril—Lisinopril—coronary artery disease	0.0219	0.0682	CrCrCtD
Labetalol—Quinapril—Ramipril—coronary artery disease	0.0212	0.066	CrCrCtD
Labetalol—Benazepril—Lisinopril—coronary artery disease	0.0209	0.065	CrCrCtD
Labetalol—Benazepril—Ramipril—coronary artery disease	0.0202	0.0629	CrCrCtD
Labetalol—CYP2D6—Niacin—coronary artery disease	0.00843	0.0306	CbGbCtD
Labetalol—CYP2D6—Timolol—coronary artery disease	0.00784	0.0285	CbGbCtD
Labetalol—CYP2D6—Captopril—coronary artery disease	0.0069	0.0251	CbGbCtD
Labetalol—CYP2D6—Simvastatin—coronary artery disease	0.00667	0.0242	CbGbCtD
Labetalol—CYP2D6—Pravastatin—coronary artery disease	0.00653	0.0237	CbGbCtD
Labetalol—CYP2D6—Lovastatin—coronary artery disease	0.00653	0.0237	CbGbCtD
Labetalol—CYP2D6—Atorvastatin—coronary artery disease	0.00594	0.0216	CbGbCtD
Labetalol—Dobutamine—CA5B—coronary artery disease	0.00033	0.123	CrCbGaD
Labetalol—Isoprenaline—MAPK1—coronary artery disease	0.000191	0.0711	CrCbGaD
Labetalol—Fenoterol—ADRB1—coronary artery disease	0.000117	0.0434	CrCbGaD
Labetalol—Arbutamine—ADRB1—coronary artery disease	0.000109	0.0406	CrCbGaD
Labetalol—Formoterol—ADRB1—coronary artery disease	0.000106	0.0394	CrCbGaD
Labetalol—Arformoterol—ADRB1—coronary artery disease	0.000106	0.0394	CrCbGaD
Labetalol—Benazepril—MTHFR—coronary artery disease	0.000105	0.0391	CrCbGaD
Labetalol—Salmeterol—ADRB2—coronary artery disease	0.000102	0.0379	CrCbGaD
Labetalol—Dobutamine—ADRB1—coronary artery disease	0.0001	0.0374	CrCbGaD
Labetalol—Quinapril—ACE—coronary artery disease	9.84e-05	0.0366	CrCbGaD
Labetalol—Fenoterol—ADRB2—coronary artery disease	9.81e-05	0.0365	CrCbGaD
Labetalol—Ritodrine—ADRB2—coronary artery disease	9.81e-05	0.0365	CrCbGaD
Labetalol—Arbutamine—ADRB2—coronary artery disease	9.18e-05	0.0341	CrCbGaD
Labetalol—Arformoterol—ADRB2—coronary artery disease	8.91e-05	0.0331	CrCbGaD
Labetalol—Formoterol—ADRB2—coronary artery disease	8.91e-05	0.0331	CrCbGaD
Labetalol—Benazepril—ACE—coronary artery disease	8.56e-05	0.0319	CrCbGaD
Labetalol—Dobutamine—ADRB2—coronary artery disease	8.45e-05	0.0314	CrCbGaD
Labetalol—Formoterol—CYP2C19—coronary artery disease	7.67e-05	0.0285	CrCbGaD
Labetalol—Arformoterol—CYP2C19—coronary artery disease	7.67e-05	0.0285	CrCbGaD
Labetalol—Ketoprofen—CXCL8—coronary artery disease	7.22e-05	0.0269	CrCbGaD
Labetalol—Propafenone—ADRB1—coronary artery disease	5.92e-05	0.022	CrCbGaD
Labetalol—Isoprenaline—ADRB1—coronary artery disease	5.7e-05	0.0212	CrCbGaD
Labetalol—Mirabegron—ALB—coronary artery disease	5.32e-05	0.0198	CrCbGaD
Labetalol—Tolterodine—CYP2C19—coronary artery disease	5.04e-05	0.0187	CrCbGaD
Labetalol—Isoprenaline—ADRB2—coronary artery disease	4.79e-05	0.0178	CrCbGaD
Labetalol—Salsalate—PTGS2—coronary artery disease	4.32e-05	0.0161	CrCbGaD
Labetalol—Vomiting—Lovastatin—coronary artery disease	4e-05	0.000358	CcSEcCtD
Labetalol—Somnolence—Losartan—coronary artery disease	4e-05	0.000357	CcSEcCtD
Labetalol—Dizziness—Eplerenone—coronary artery disease	3.99e-05	0.000357	CcSEcCtD
Labetalol—Rash—Clopidogrel—coronary artery disease	3.99e-05	0.000357	CcSEcCtD
Labetalol—Dermatitis—Clopidogrel—coronary artery disease	3.99e-05	0.000357	CcSEcCtD
Labetalol—Asthenia—Valsartan—coronary artery disease	3.99e-05	0.000357	CcSEcCtD
Labetalol—Hypertension—Timolol—coronary artery disease	3.99e-05	0.000356	CcSEcCtD
Labetalol—Pain—Furosemide—coronary artery disease	3.98e-05	0.000356	CcSEcCtD
Labetalol—Constipation—Furosemide—coronary artery disease	3.98e-05	0.000356	CcSEcCtD
Labetalol—Hypersensitivity—Niacin—coronary artery disease	3.98e-05	0.000356	CcSEcCtD
Labetalol—Ill-defined disorder—Lisinopril—coronary artery disease	3.97e-05	0.000355	CcSEcCtD
Labetalol—Discomfort—Ramipril—coronary artery disease	3.97e-05	0.000355	CcSEcCtD
Labetalol—Asthenia—Olmesartan—coronary artery disease	3.97e-05	0.000355	CcSEcCtD
Labetalol—Headache—Clopidogrel—coronary artery disease	3.97e-05	0.000355	CcSEcCtD
Labetalol—Rash—Lovastatin—coronary artery disease	3.97e-05	0.000355	CcSEcCtD
Labetalol—Dermatitis—Lovastatin—coronary artery disease	3.96e-05	0.000354	CcSEcCtD
Labetalol—Dyspepsia—Losartan—coronary artery disease	3.96e-05	0.000354	CcSEcCtD
Labetalol—Feeling abnormal—Perindopril—coronary artery disease	3.95e-05	0.000353	CcSEcCtD
Labetalol—Headache—Lovastatin—coronary artery disease	3.94e-05	0.000352	CcSEcCtD
Labetalol—Pruritus—Valsartan—coronary artery disease	3.93e-05	0.000352	CcSEcCtD
Labetalol—Vomiting—Ezetimibe—coronary artery disease	3.92e-05	0.000351	CcSEcCtD
Labetalol—Hypersensitivity—Pravastatin—coronary artery disease	3.92e-05	0.000351	CcSEcCtD
Labetalol—Gastrointestinal pain—Perindopril—coronary artery disease	3.92e-05	0.00035	CcSEcCtD
Labetalol—Angioedema—Lisinopril—coronary artery disease	3.91e-05	0.00035	CcSEcCtD
Labetalol—Pruritus—Olmesartan—coronary artery disease	3.91e-05	0.00035	CcSEcCtD
Labetalol—Body temperature increased—Captopril—coronary artery disease	3.9e-05	0.000349	CcSEcCtD
Labetalol—Abdominal pain—Captopril—coronary artery disease	3.9e-05	0.000349	CcSEcCtD
Labetalol—Dizziness—Simvastatin—coronary artery disease	3.89e-05	0.000348	CcSEcCtD
Labetalol—Rash—Ezetimibe—coronary artery disease	3.89e-05	0.000348	CcSEcCtD
Labetalol—Dermatitis—Ezetimibe—coronary artery disease	3.89e-05	0.000348	CcSEcCtD
Labetalol—Confusional state—Ramipril—coronary artery disease	3.89e-05	0.000347	CcSEcCtD
Labetalol—Discomfort—Timolol—coronary artery disease	3.88e-05	0.000347	CcSEcCtD
Labetalol—Asthenia—Niacin—coronary artery disease	3.88e-05	0.000347	CcSEcCtD
Labetalol—Fatigue—Losartan—coronary artery disease	3.87e-05	0.000346	CcSEcCtD
Labetalol—Headache—Ezetimibe—coronary artery disease	3.87e-05	0.000346	CcSEcCtD
Labetalol—Malaise—Lisinopril—coronary artery disease	3.86e-05	0.000345	CcSEcCtD
Labetalol—Oedema—Ramipril—coronary artery disease	3.85e-05	0.000345	CcSEcCtD
Labetalol—Anaphylactic shock—Ramipril—coronary artery disease	3.85e-05	0.000345	CcSEcCtD
Labetalol—Vertigo—Lisinopril—coronary artery disease	3.85e-05	0.000344	CcSEcCtD
Labetalol—Pain—Losartan—coronary artery disease	3.84e-05	0.000344	CcSEcCtD
Labetalol—Constipation—Losartan—coronary artery disease	3.84e-05	0.000344	CcSEcCtD
Labetalol—Syncope—Lisinopril—coronary artery disease	3.84e-05	0.000343	CcSEcCtD
Labetalol—Vomiting—Eplerenone—coronary artery disease	3.84e-05	0.000343	CcSEcCtD
Labetalol—Feeling abnormal—Furosemide—coronary artery disease	3.84e-05	0.000343	CcSEcCtD
Labetalol—Nausea—Fenofibrate—coronary artery disease	3.83e-05	0.000342	CcSEcCtD
Labetalol—Pruritus—Niacin—coronary artery disease	3.82e-05	0.000342	CcSEcCtD
Labetalol—Asthenia—Pravastatin—coronary artery disease	3.82e-05	0.000341	CcSEcCtD
Labetalol—Gastrointestinal pain—Furosemide—coronary artery disease	3.81e-05	0.000341	CcSEcCtD
Labetalol—Rash—Eplerenone—coronary artery disease	3.81e-05	0.000341	CcSEcCtD
Labetalol—Urticaria—Perindopril—coronary artery disease	3.81e-05	0.00034	CcSEcCtD
Labetalol—Hypersensitivity—Trandolapril—coronary artery disease	3.81e-05	0.00034	CcSEcCtD
Labetalol—Dermatitis—Eplerenone—coronary artery disease	3.8e-05	0.00034	CcSEcCtD
Labetalol—Diarrhoea—Valsartan—coronary artery disease	3.8e-05	0.00034	CcSEcCtD
Labetalol—Confusional state—Timolol—coronary artery disease	3.8e-05	0.00034	CcSEcCtD
Labetalol—Shock—Ramipril—coronary artery disease	3.79e-05	0.000339	CcSEcCtD
Labetalol—Hypersensitivity—Enalapril—coronary artery disease	3.79e-05	0.000339	CcSEcCtD
Labetalol—Abdominal pain—Perindopril—coronary artery disease	3.79e-05	0.000339	CcSEcCtD
Labetalol—Body temperature increased—Perindopril—coronary artery disease	3.79e-05	0.000339	CcSEcCtD
Labetalol—Palpitations—Lisinopril—coronary artery disease	3.78e-05	0.000338	CcSEcCtD
Labetalol—Diarrhoea—Olmesartan—coronary artery disease	3.78e-05	0.000338	CcSEcCtD
Labetalol—Headache—Eplerenone—coronary artery disease	3.78e-05	0.000338	CcSEcCtD
Labetalol—Anaphylactic shock—Timolol—coronary artery disease	3.77e-05	0.000337	CcSEcCtD
Labetalol—Oedema—Timolol—coronary artery disease	3.77e-05	0.000337	CcSEcCtD
Labetalol—Pruritus—Pravastatin—coronary artery disease	3.76e-05	0.000337	CcSEcCtD
Labetalol—Loss of consciousness—Lisinopril—coronary artery disease	3.76e-05	0.000337	CcSEcCtD
Labetalol—Nausea—Clopidogrel—coronary artery disease	3.76e-05	0.000336	CcSEcCtD
Labetalol—Vomiting—Simvastatin—coronary artery disease	3.74e-05	0.000335	CcSEcCtD
Labetalol—Hypersensitivity—Telmisartan—coronary artery disease	3.74e-05	0.000334	CcSEcCtD
Labetalol—Nausea—Lovastatin—coronary artery disease	3.74e-05	0.000334	CcSEcCtD
Labetalol—Hyperhidrosis—Ramipril—coronary artery disease	3.73e-05	0.000333	CcSEcCtD
Labetalol—Rash—Simvastatin—coronary artery disease	3.71e-05	0.000332	CcSEcCtD
Labetalol—Dermatitis—Simvastatin—coronary artery disease	3.71e-05	0.000331	CcSEcCtD
Labetalol—Asthenia—Trandolapril—coronary artery disease	3.71e-05	0.000331	CcSEcCtD
Labetalol—Shock—Timolol—coronary artery disease	3.71e-05	0.000331	CcSEcCtD
Labetalol—Feeling abnormal—Losartan—coronary artery disease	3.7e-05	0.000331	CcSEcCtD
Labetalol—Urticaria—Furosemide—coronary artery disease	3.7e-05	0.000331	CcSEcCtD
Labetalol—Diarrhoea—Niacin—coronary artery disease	3.7e-05	0.000331	CcSEcCtD
Labetalol—Asthenia—Enalapril—coronary artery disease	3.69e-05	0.00033	CcSEcCtD
Labetalol—Headache—Simvastatin—coronary artery disease	3.69e-05	0.00033	CcSEcCtD
Labetalol—Abdominal pain—Furosemide—coronary artery disease	3.68e-05	0.000329	CcSEcCtD
Labetalol—Body temperature increased—Furosemide—coronary artery disease	3.68e-05	0.000329	CcSEcCtD
Labetalol—Gastrointestinal pain—Losartan—coronary artery disease	3.68e-05	0.000329	CcSEcCtD
Labetalol—Dizziness—Valsartan—coronary artery disease	3.67e-05	0.000329	CcSEcCtD
Labetalol—Nausea—Ezetimibe—coronary artery disease	3.67e-05	0.000328	CcSEcCtD
Labetalol—Dizziness—Olmesartan—coronary artery disease	3.66e-05	0.000327	CcSEcCtD
Labetalol—Pruritus—Trandolapril—coronary artery disease	3.66e-05	0.000327	CcSEcCtD
Labetalol—Hyperhidrosis—Timolol—coronary artery disease	3.64e-05	0.000326	CcSEcCtD
Labetalol—Asthenia—Telmisartan—coronary artery disease	3.64e-05	0.000326	CcSEcCtD
Labetalol—Pruritus—Enalapril—coronary artery disease	3.64e-05	0.000326	CcSEcCtD
Labetalol—Diarrhoea—Pravastatin—coronary artery disease	3.64e-05	0.000326	CcSEcCtD
Labetalol—Discomfort—Lisinopril—coronary artery disease	3.6e-05	0.000322	CcSEcCtD
Labetalol—Hypotension—Ramipril—coronary artery disease	3.6e-05	0.000322	CcSEcCtD
Labetalol—Pruritus—Telmisartan—coronary artery disease	3.59e-05	0.000321	CcSEcCtD
Labetalol—Nausea—Eplerenone—coronary artery disease	3.59e-05	0.000321	CcSEcCtD
Labetalol—Dizziness—Niacin—coronary artery disease	3.57e-05	0.00032	CcSEcCtD
Labetalol—Urticaria—Losartan—coronary artery disease	3.57e-05	0.000319	CcSEcCtD
Labetalol—Fenoprofen—PTGS2—coronary artery disease	3.57e-05	0.0133	CrCbGaD
Labetalol—Abdominal pain—Losartan—coronary artery disease	3.55e-05	0.000318	CcSEcCtD
Labetalol—Body temperature increased—Losartan—coronary artery disease	3.55e-05	0.000318	CcSEcCtD
Labetalol—Asthenia—Captopril—coronary artery disease	3.54e-05	0.000317	CcSEcCtD
Labetalol—Diarrhoea—Trandolapril—coronary artery disease	3.53e-05	0.000316	CcSEcCtD
Labetalol—Vomiting—Valsartan—coronary artery disease	3.53e-05	0.000316	CcSEcCtD
Labetalol—Confusional state—Lisinopril—coronary artery disease	3.52e-05	0.000315	CcSEcCtD
Labetalol—Diarrhoea—Enalapril—coronary artery disease	3.52e-05	0.000315	CcSEcCtD
Labetalol—Hypotension—Timolol—coronary artery disease	3.52e-05	0.000315	CcSEcCtD
Labetalol—Dizziness—Pravastatin—coronary artery disease	3.52e-05	0.000315	CcSEcCtD
Labetalol—Vomiting—Olmesartan—coronary artery disease	3.52e-05	0.000314	CcSEcCtD
Labetalol—Rash—Valsartan—coronary artery disease	3.5e-05	0.000313	CcSEcCtD
Labetalol—Dermatitis—Valsartan—coronary artery disease	3.5e-05	0.000313	CcSEcCtD
Labetalol—Nausea—Simvastatin—coronary artery disease	3.5e-05	0.000313	CcSEcCtD
Labetalol—Oedema—Lisinopril—coronary artery disease	3.5e-05	0.000313	CcSEcCtD
Labetalol—Anaphylactic shock—Lisinopril—coronary artery disease	3.5e-05	0.000313	CcSEcCtD
Labetalol—Pruritus—Captopril—coronary artery disease	3.49e-05	0.000312	CcSEcCtD
Labetalol—Rash—Olmesartan—coronary artery disease	3.49e-05	0.000312	CcSEcCtD
Labetalol—Dermatitis—Olmesartan—coronary artery disease	3.48e-05	0.000312	CcSEcCtD
Labetalol—Headache—Valsartan—coronary artery disease	3.48e-05	0.000311	CcSEcCtD
Labetalol—Diarrhoea—Telmisartan—coronary artery disease	3.47e-05	0.000311	CcSEcCtD
Labetalol—Headache—Olmesartan—coronary artery disease	3.46e-05	0.00031	CcSEcCtD
Labetalol—Paraesthesia—Ramipril—coronary artery disease	3.46e-05	0.000309	CcSEcCtD
Labetalol—Shock—Lisinopril—coronary artery disease	3.44e-05	0.000307	CcSEcCtD
Labetalol—Asthenia—Perindopril—coronary artery disease	3.44e-05	0.000307	CcSEcCtD
Labetalol—Dyspnoea—Ramipril—coronary artery disease	3.44e-05	0.000307	CcSEcCtD
Labetalol—Vomiting—Niacin—coronary artery disease	3.44e-05	0.000307	CcSEcCtD
Labetalol—Hypersensitivity—Furosemide—coronary artery disease	3.43e-05	0.000307	CcSEcCtD
Labetalol—Somnolence—Ramipril—coronary artery disease	3.43e-05	0.000306	CcSEcCtD
Labetalol—Dizziness—Trandolapril—coronary artery disease	3.42e-05	0.000305	CcSEcCtD
Labetalol—Rash—Niacin—coronary artery disease	3.41e-05	0.000305	CcSEcCtD
Labetalol—Dermatitis—Niacin—coronary artery disease	3.4e-05	0.000304	CcSEcCtD
Labetalol—Dizziness—Enalapril—coronary artery disease	3.4e-05	0.000304	CcSEcCtD
Labetalol—Dyspepsia—Ramipril—coronary artery disease	3.39e-05	0.000303	CcSEcCtD
Labetalol—Pruritus—Perindopril—coronary artery disease	3.39e-05	0.000303	CcSEcCtD
Labetalol—Headache—Niacin—coronary artery disease	3.39e-05	0.000303	CcSEcCtD
Labetalol—Paraesthesia—Timolol—coronary artery disease	3.38e-05	0.000303	CcSEcCtD
Labetalol—Vomiting—Pravastatin—coronary artery disease	3.38e-05	0.000302	CcSEcCtD
Labetalol—Hyperhidrosis—Lisinopril—coronary artery disease	3.38e-05	0.000302	CcSEcCtD
Labetalol—Diarrhoea—Captopril—coronary artery disease	3.38e-05	0.000302	CcSEcCtD
Labetalol—Dyspnoea—Timolol—coronary artery disease	3.36e-05	0.0003	CcSEcCtD
Labetalol—Dizziness—Telmisartan—coronary artery disease	3.36e-05	0.0003	CcSEcCtD
Labetalol—Rash—Pravastatin—coronary artery disease	3.35e-05	0.0003	CcSEcCtD
Labetalol—Dermatitis—Pravastatin—coronary artery disease	3.35e-05	0.0003	CcSEcCtD
Labetalol—Somnolence—Timolol—coronary artery disease	3.35e-05	0.0003	CcSEcCtD
Labetalol—Asthenia—Furosemide—coronary artery disease	3.34e-05	0.000299	CcSEcCtD
Labetalol—Headache—Pravastatin—coronary artery disease	3.33e-05	0.000298	CcSEcCtD
Labetalol—Fatigue—Ramipril—coronary artery disease	3.32e-05	0.000297	CcSEcCtD
Labetalol—Dyspepsia—Timolol—coronary artery disease	3.32e-05	0.000297	CcSEcCtD
Labetalol—Hypersensitivity—Losartan—coronary artery disease	3.31e-05	0.000296	CcSEcCtD
Labetalol—Nausea—Valsartan—coronary artery disease	3.3e-05	0.000295	CcSEcCtD
Labetalol—Pruritus—Furosemide—coronary artery disease	3.3e-05	0.000295	CcSEcCtD
Labetalol—Constipation—Ramipril—coronary artery disease	3.3e-05	0.000295	CcSEcCtD
Labetalol—Nausea—Olmesartan—coronary artery disease	3.29e-05	0.000294	CcSEcCtD
Labetalol—Vomiting—Trandolapril—coronary artery disease	3.28e-05	0.000294	CcSEcCtD
Labetalol—Diarrhoea—Perindopril—coronary artery disease	3.28e-05	0.000293	CcSEcCtD
Labetalol—Vomiting—Enalapril—coronary artery disease	3.27e-05	0.000293	CcSEcCtD
Labetalol—Hypotension—Lisinopril—coronary artery disease	3.27e-05	0.000292	CcSEcCtD
Labetalol—Dizziness—Captopril—coronary artery disease	3.26e-05	0.000292	CcSEcCtD
Labetalol—Rash—Trandolapril—coronary artery disease	3.26e-05	0.000291	CcSEcCtD
Labetalol—Dermatitis—Trandolapril—coronary artery disease	3.25e-05	0.000291	CcSEcCtD
Labetalol—Fatigue—Timolol—coronary artery disease	3.25e-05	0.00029	CcSEcCtD
Labetalol—Rash—Enalapril—coronary artery disease	3.24e-05	0.00029	CcSEcCtD
Labetalol—Dermatitis—Enalapril—coronary artery disease	3.24e-05	0.00029	CcSEcCtD
Labetalol—Headache—Trandolapril—coronary artery disease	3.24e-05	0.000289	CcSEcCtD
Labetalol—Vomiting—Telmisartan—coronary artery disease	3.23e-05	0.000289	CcSEcCtD
Labetalol—Asthenia—Losartan—coronary artery disease	3.22e-05	0.000288	CcSEcCtD
Labetalol—Headache—Enalapril—coronary artery disease	3.22e-05	0.000288	CcSEcCtD
Labetalol—Pain—Timolol—coronary artery disease	3.22e-05	0.000288	CcSEcCtD
Labetalol—Nausea—Niacin—coronary artery disease	3.21e-05	0.000287	CcSEcCtD
Labetalol—Rash—Telmisartan—coronary artery disease	3.2e-05	0.000286	CcSEcCtD
Labetalol—Dermatitis—Telmisartan—coronary artery disease	3.2e-05	0.000286	CcSEcCtD
Labetalol—Diarrhoea—Furosemide—coronary artery disease	3.19e-05	0.000285	CcSEcCtD
Labetalol—Pruritus—Losartan—coronary artery disease	3.18e-05	0.000284	CcSEcCtD
Labetalol—Headache—Telmisartan—coronary artery disease	3.18e-05	0.000284	CcSEcCtD
Labetalol—Fenoprofen—ALB—coronary artery disease	3.18e-05	0.0118	CrCbGaD
Labetalol—Feeling abnormal—Ramipril—coronary artery disease	3.18e-05	0.000284	CcSEcCtD
Labetalol—Dizziness—Perindopril—coronary artery disease	3.17e-05	0.000283	CcSEcCtD
Labetalol—Nausea—Pravastatin—coronary artery disease	3.16e-05	0.000283	CcSEcCtD
Labetalol—Gastrointestinal pain—Ramipril—coronary artery disease	3.15e-05	0.000282	CcSEcCtD
Labetalol—Paraesthesia—Lisinopril—coronary artery disease	3.14e-05	0.000281	CcSEcCtD
Labetalol—Vomiting—Captopril—coronary artery disease	3.14e-05	0.000281	CcSEcCtD
Labetalol—Dyspnoea—Lisinopril—coronary artery disease	3.12e-05	0.000279	CcSEcCtD
Labetalol—Rash—Captopril—coronary artery disease	3.11e-05	0.000278	CcSEcCtD
Labetalol—Dermatitis—Captopril—coronary artery disease	3.11e-05	0.000278	CcSEcCtD
Labetalol—Somnolence—Lisinopril—coronary artery disease	3.11e-05	0.000278	CcSEcCtD
Labetalol—Feeling abnormal—Timolol—coronary artery disease	3.1e-05	0.000278	CcSEcCtD
Labetalol—Headache—Captopril—coronary artery disease	3.09e-05	0.000276	CcSEcCtD
Labetalol—Gastrointestinal pain—Timolol—coronary artery disease	3.08e-05	0.000275	CcSEcCtD
Labetalol—Dizziness—Furosemide—coronary artery disease	3.08e-05	0.000275	CcSEcCtD
Labetalol—Dyspepsia—Lisinopril—coronary artery disease	3.08e-05	0.000275	CcSEcCtD
Labetalol—Diarrhoea—Losartan—coronary artery disease	3.08e-05	0.000275	CcSEcCtD
Labetalol—Nausea—Trandolapril—coronary artery disease	3.07e-05	0.000274	CcSEcCtD
Labetalol—Urticaria—Ramipril—coronary artery disease	3.06e-05	0.000274	CcSEcCtD
Labetalol—Nausea—Enalapril—coronary artery disease	3.06e-05	0.000273	CcSEcCtD
Labetalol—Vomiting—Perindopril—coronary artery disease	3.05e-05	0.000272	CcSEcCtD
Labetalol—Abdominal pain—Ramipril—coronary artery disease	3.05e-05	0.000272	CcSEcCtD
Labetalol—Body temperature increased—Ramipril—coronary artery disease	3.05e-05	0.000272	CcSEcCtD
Labetalol—Rash—Perindopril—coronary artery disease	3.02e-05	0.00027	CcSEcCtD
Labetalol—Dermatitis—Perindopril—coronary artery disease	3.02e-05	0.00027	CcSEcCtD
Labetalol—Nausea—Telmisartan—coronary artery disease	3.01e-05	0.00027	CcSEcCtD
Labetalol—Fatigue—Lisinopril—coronary artery disease	3.01e-05	0.000269	CcSEcCtD
Labetalol—Headache—Perindopril—coronary artery disease	3e-05	0.000268	CcSEcCtD
Labetalol—Urticaria—Timolol—coronary artery disease	2.99e-05	0.000268	CcSEcCtD
Labetalol—Constipation—Lisinopril—coronary artery disease	2.99e-05	0.000267	CcSEcCtD
Labetalol—Pain—Lisinopril—coronary artery disease	2.99e-05	0.000267	CcSEcCtD
Labetalol—Abdominal pain—Timolol—coronary artery disease	2.98e-05	0.000266	CcSEcCtD
Labetalol—Body temperature increased—Timolol—coronary artery disease	2.98e-05	0.000266	CcSEcCtD
Labetalol—Dizziness—Losartan—coronary artery disease	2.97e-05	0.000266	CcSEcCtD
Labetalol—Vomiting—Furosemide—coronary artery disease	2.96e-05	0.000265	CcSEcCtD
Labetalol—Rash—Furosemide—coronary artery disease	2.94e-05	0.000263	CcSEcCtD
Labetalol—Dermatitis—Furosemide—coronary artery disease	2.93e-05	0.000262	CcSEcCtD
Labetalol—Nausea—Captopril—coronary artery disease	2.93e-05	0.000262	CcSEcCtD
Labetalol—Headache—Furosemide—coronary artery disease	2.92e-05	0.000261	CcSEcCtD
Labetalol—Feeling abnormal—Lisinopril—coronary artery disease	2.88e-05	0.000258	CcSEcCtD
Labetalol—Gastrointestinal pain—Lisinopril—coronary artery disease	2.86e-05	0.000256	CcSEcCtD
Labetalol—Vomiting—Losartan—coronary artery disease	2.86e-05	0.000256	CcSEcCtD
Labetalol—Nausea—Perindopril—coronary artery disease	2.85e-05	0.000255	CcSEcCtD
Labetalol—Hypersensitivity—Ramipril—coronary artery disease	2.84e-05	0.000254	CcSEcCtD
Labetalol—Rash—Losartan—coronary artery disease	2.83e-05	0.000253	CcSEcCtD
Labetalol—Dermatitis—Losartan—coronary artery disease	2.83e-05	0.000253	CcSEcCtD
Labetalol—Headache—Losartan—coronary artery disease	2.82e-05	0.000252	CcSEcCtD
Labetalol—Urticaria—Lisinopril—coronary artery disease	2.78e-05	0.000248	CcSEcCtD
Labetalol—Hypersensitivity—Timolol—coronary artery disease	2.78e-05	0.000248	CcSEcCtD
Labetalol—Nausea—Furosemide—coronary artery disease	2.77e-05	0.000247	CcSEcCtD
Labetalol—Asthenia—Ramipril—coronary artery disease	2.77e-05	0.000247	CcSEcCtD
Labetalol—Abdominal pain—Lisinopril—coronary artery disease	2.76e-05	0.000247	CcSEcCtD
Labetalol—Body temperature increased—Lisinopril—coronary artery disease	2.76e-05	0.000247	CcSEcCtD
Labetalol—Pruritus—Ramipril—coronary artery disease	2.73e-05	0.000244	CcSEcCtD
Labetalol—Asthenia—Timolol—coronary artery disease	2.7e-05	0.000242	CcSEcCtD
Labetalol—Nausea—Losartan—coronary artery disease	2.67e-05	0.000239	CcSEcCtD
Labetalol—Pruritus—Timolol—coronary artery disease	2.67e-05	0.000238	CcSEcCtD
Labetalol—Diarrhoea—Ramipril—coronary artery disease	2.64e-05	0.000236	CcSEcCtD
Labetalol—Diarrhoea—Timolol—coronary artery disease	2.58e-05	0.000231	CcSEcCtD
Labetalol—Hypersensitivity—Lisinopril—coronary artery disease	2.58e-05	0.00023	CcSEcCtD
Labetalol—Dizziness—Ramipril—coronary artery disease	2.55e-05	0.000228	CcSEcCtD
Labetalol—Asthenia—Lisinopril—coronary artery disease	2.51e-05	0.000224	CcSEcCtD
Labetalol—Dizziness—Timolol—coronary artery disease	2.49e-05	0.000223	CcSEcCtD
Labetalol—Pruritus—Lisinopril—coronary artery disease	2.47e-05	0.000221	CcSEcCtD
Labetalol—Vomiting—Ramipril—coronary artery disease	2.45e-05	0.000219	CcSEcCtD
Labetalol—Rash—Ramipril—coronary artery disease	2.43e-05	0.000217	CcSEcCtD
Labetalol—Dermatitis—Ramipril—coronary artery disease	2.43e-05	0.000217	CcSEcCtD
Labetalol—Headache—Ramipril—coronary artery disease	2.41e-05	0.000216	CcSEcCtD
Labetalol—Vomiting—Timolol—coronary artery disease	2.4e-05	0.000214	CcSEcCtD
Labetalol—Diarrhoea—Lisinopril—coronary artery disease	2.39e-05	0.000214	CcSEcCtD
Labetalol—Rash—Timolol—coronary artery disease	2.38e-05	0.000212	CcSEcCtD
Labetalol—Dermatitis—Timolol—coronary artery disease	2.37e-05	0.000212	CcSEcCtD
Labetalol—Headache—Timolol—coronary artery disease	2.36e-05	0.000211	CcSEcCtD
Labetalol—Flurbiprofen—PTGS2—coronary artery disease	2.33e-05	0.00866	CrCbGaD
Labetalol—Dizziness—Lisinopril—coronary artery disease	2.31e-05	0.000207	CcSEcCtD
Labetalol—Nausea—Ramipril—coronary artery disease	2.29e-05	0.000205	CcSEcCtD
Labetalol—Nausea—Timolol—coronary artery disease	2.24e-05	0.0002	CcSEcCtD
Labetalol—Vomiting—Lisinopril—coronary artery disease	2.22e-05	0.000199	CcSEcCtD
Labetalol—Rash—Lisinopril—coronary artery disease	2.2e-05	0.000197	CcSEcCtD
Labetalol—Dermatitis—Lisinopril—coronary artery disease	2.2e-05	0.000197	CcSEcCtD
Labetalol—Headache—Lisinopril—coronary artery disease	2.19e-05	0.000196	CcSEcCtD
Labetalol—Ketoprofen—PTGS2—coronary artery disease	2.11e-05	0.00783	CrCbGaD
Labetalol—Nausea—Lisinopril—coronary artery disease	2.08e-05	0.000186	CcSEcCtD
Labetalol—Flurbiprofen—ALB—coronary artery disease	2.07e-05	0.00772	CrCbGaD
Labetalol—Ketoprofen—ALB—coronary artery disease	1.88e-05	0.00698	CrCbGaD
Labetalol—CYP2D6—Metabolism—HADH—coronary artery disease	5.59e-06	0.000136	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6ST—coronary artery disease	5.58e-06	0.000136	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—F2—coronary artery disease	5.58e-06	0.000136	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—FN1—coronary artery disease	5.58e-06	0.000136	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6ST—coronary artery disease	5.55e-06	0.000135	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—JUNB—coronary artery disease	5.52e-06	0.000134	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NFKBIA—coronary artery disease	5.51e-06	0.000134	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—BDKRB2—coronary artery disease	5.51e-06	0.000134	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL12—coronary artery disease	5.51e-06	0.000134	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PLCB1—coronary artery disease	5.5e-06	0.000134	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—POMC—coronary artery disease	5.5e-06	0.000134	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—F2—coronary artery disease	5.48e-06	0.000133	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6ST—coronary artery disease	5.46e-06	0.000133	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—JUNB—coronary artery disease	5.4e-06	0.000131	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR7—coronary artery disease	5.39e-06	0.000131	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PLCB1—coronary artery disease	5.38e-06	0.000131	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—KIT—coronary artery disease	5.34e-06	0.00013	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	5.3e-06	0.000129	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA2—coronary artery disease	5.3e-06	0.000129	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GPX2—coronary artery disease	5.3e-06	0.000129	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR7—coronary artery disease	5.27e-06	0.000128	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HK1—coronary artery disease	5.24e-06	0.000127	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SULT1A1—coronary artery disease	5.24e-06	0.000127	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCG5—coronary artery disease	5.24e-06	0.000127	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GPX4—coronary artery disease	5.24e-06	0.000127	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HADHA—coronary artery disease	5.18e-06	0.000126	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ITGAV—coronary artery disease	5.14e-06	0.000125	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GSK3B—coronary artery disease	5.12e-06	0.000125	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KNG1—coronary artery disease	5.12e-06	0.000125	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTA1—coronary artery disease	5.12e-06	0.000124	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—POMC—coronary artery disease	5.1e-06	0.000124	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CREB1—coronary artery disease	5.1e-06	0.000124	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGTR1—coronary artery disease	5.09e-06	0.000124	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—POMC—coronary artery disease	5.08e-06	0.000124	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CREB1—coronary artery disease	5.08e-06	0.000124	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPA—coronary artery disease	5.06e-06	0.000123	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ITGAV—coronary artery disease	5.02e-06	0.000122	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KNG1—coronary artery disease	5.01e-06	0.000122	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL2—coronary artery disease	4.99e-06	0.000121	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—POMC—coronary artery disease	4.99e-06	0.000121	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CREB1—coronary artery disease	4.99e-06	0.000121	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGTR1—coronary artery disease	4.98e-06	0.000121	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6R—coronary artery disease	4.98e-06	0.000121	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL10—coronary artery disease	4.97e-06	0.000121	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL2—coronary artery disease	4.97e-06	0.000121	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PLG—coronary artery disease	4.96e-06	0.000121	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6R—coronary artery disease	4.95e-06	0.00012	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLCB3—coronary artery disease	4.9e-06	0.000119	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF1—coronary artery disease	4.89e-06	0.000119	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	4.88e-06	0.000119	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	4.87e-06	0.000118	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	4.87e-06	0.000118	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—MAPK1—coronary artery disease	4.86e-06	0.000118	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PLG—coronary artery disease	4.85e-06	0.000118	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA5—coronary artery disease	4.85e-06	0.000118	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	4.83e-06	0.000117	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	4.77e-06	0.000116	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	4.76e-06	0.000116	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—P4HB—coronary artery disease	4.76e-06	0.000116	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	4.76e-06	0.000116	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—S100B—coronary artery disease	4.74e-06	0.000115	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	4.7e-06	0.000114	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	4.67e-06	0.000114	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	4.66e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	4.66e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	4.65e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PIK3CA—coronary artery disease	4.65e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	4.64e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	4.64e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—S100B—coronary artery disease	4.64e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SERPINE1—coronary artery disease	4.64e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	4.59e-06	0.000112	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	4.54e-06	0.00011	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	4.54e-06	0.00011	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	4.54e-06	0.00011	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	4.54e-06	0.00011	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—FGF2—coronary artery disease	4.49e-06	0.000109	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	4.44e-06	0.000108	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	4.44e-06	0.000108	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NOS3—coronary artery disease	4.43e-06	0.000108	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—VCAN—coronary artery disease	4.4e-06	0.000107	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOB—coronary artery disease	4.38e-06	0.000107	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALDOA—coronary artery disease	4.37e-06	0.000106	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	4.35e-06	0.000106	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	4.33e-06	0.000105	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	4.31e-06	0.000105	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—JAK2—coronary artery disease	4.3e-06	0.000105	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOB—coronary artery disease	4.29e-06	0.000104	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	4.28e-06	0.000104	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	4.25e-06	0.000103	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DCN—coronary artery disease	4.24e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	4.23e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	4.22e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PIK3CA—coronary artery disease	4.22e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	4.22e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	4.22e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	4.19e-06	0.000102	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LPL—coronary artery disease	4.19e-06	0.000102	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	4.15e-06	0.000101	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	4.15e-06	0.000101	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	4.13e-06	0.0001	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	4.13e-06	0.0001	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALDH2—coronary artery disease	4.12e-06	0.0001	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LPL—coronary artery disease	4.1e-06	9.96e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	4.06e-06	9.87e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	4.06e-06	9.87e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	4.04e-06	9.83e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	4.02e-06	9.77e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LIPC—coronary artery disease	4.02e-06	9.77e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HBA1—coronary artery disease	4.02e-06	9.77e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2C19—coronary artery disease	4.02e-06	9.77e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOC3—coronary artery disease	3.99e-06	9.71e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LDLR—coronary artery disease	3.97e-06	9.66e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	3.96e-06	9.62e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	3.95e-06	9.6e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCL8—coronary artery disease	3.93e-06	9.56e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	3.93e-06	9.55e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC9A1—coronary artery disease	3.92e-06	9.54e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTT1—coronary artery disease	3.92e-06	9.54e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GCLC—coronary artery disease	3.88e-06	9.43e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CETP—coronary artery disease	3.88e-06	9.43e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	3.86e-06	9.39e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	3.86e-06	9.38e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	3.84e-06	9.34e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SDC1—coronary artery disease	3.83e-06	9.33e-05	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AKT1—coronary artery disease	3.8e-06	9.23e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	3.77e-06	9.18e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	3.77e-06	9.18e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—C3—coronary artery disease	3.77e-06	9.17e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CASP3—coronary artery disease	3.76e-06	9.15e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—coronary artery disease	3.74e-06	9.09e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	3.69e-06	8.98e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—C3—coronary artery disease	3.69e-06	8.97e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCND1—coronary artery disease	3.66e-06	8.9e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PSMB5—coronary artery disease	3.62e-06	8.81e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PSMA6—coronary artery disease	3.62e-06	8.81e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	3.59e-06	8.74e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGT—coronary artery disease	3.58e-06	8.71e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MMP9—coronary artery disease	3.55e-06	8.64e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CTGF—coronary artery disease	3.54e-06	8.61e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	3.52e-06	8.55e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOE—coronary artery disease	3.51e-06	8.53e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LEP—coronary artery disease	3.51e-06	8.53e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMGCR—coronary artery disease	3.51e-06	8.53e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GOT2—coronary artery disease	3.51e-06	8.53e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGT—coronary artery disease	3.5e-06	8.52e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	3.47e-06	8.44e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AKT1—coronary artery disease	3.45e-06	8.38e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KDR—coronary artery disease	3.44e-06	8.36e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LEP—coronary artery disease	3.43e-06	8.35e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOE—coronary artery disease	3.43e-06	8.35e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	3.42e-06	8.31e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	3.39e-06	8.25e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KDR—coronary artery disease	3.36e-06	8.18e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	3.35e-06	8.15e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	3.34e-06	8.13e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—F2—coronary artery disease	3.31e-06	8.05e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FN1—coronary artery disease	3.31e-06	8.05e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	3.3e-06	8.02e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	3.28e-06	7.97e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	3.27e-06	7.95e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FN1—coronary artery disease	3.24e-06	7.87e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—F2—coronary artery disease	3.24e-06	7.87e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.22e-06	7.84e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	3.22e-06	7.84e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	3.2e-06	7.78e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—VEGFA—coronary artery disease	3.19e-06	7.76e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KIT—coronary artery disease	3.17e-06	7.7e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.13e-06	7.6e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KIT—coronary artery disease	3.1e-06	7.53e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	3.04e-06	7.39e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GOT1—coronary artery disease	3.03e-06	7.36e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GGT1—coronary artery disease	3.03e-06	7.36e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—POMC—coronary artery disease	3.01e-06	7.33e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	3.01e-06	7.33e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	2.97e-06	7.23e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	2.95e-06	7.17e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—POMC—coronary artery disease	2.95e-06	7.17e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	2.95e-06	7.17e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	2.94e-06	7.15e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TGFB1—coronary artery disease	2.93e-06	7.12e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	2.9e-06	7.05e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	2.89e-06	7.02e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	2.89e-06	7.02e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	2.88e-06	7e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK1—coronary artery disease	2.87e-06	6.99e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	2.84e-06	6.9e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	2.82e-06	6.87e-05	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.76e-06	6.71e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	2.75e-06	6.7e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.72e-06	6.61e-05	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	2.7e-06	6.56e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.69e-06	6.55e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	2.69e-06	6.55e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.68e-06	6.52e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	2.67e-06	6.48e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CAT—coronary artery disease	2.65e-06	6.44e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	2.63e-06	6.39e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	2.61e-06	6.34e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	2.57e-06	6.25e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOB—coronary artery disease	2.57e-06	6.25e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	2.56e-06	6.21e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	2.5e-06	6.09e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	2.5e-06	6.08e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.5e-06	6.08e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CA—coronary artery disease	2.49e-06	6.06e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPL—coronary artery disease	2.45e-06	5.97e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	2.45e-06	5.96e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GPX1—coronary artery disease	2.39e-06	5.82e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	2.33e-06	5.67e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CD36—coronary artery disease	2.33e-06	5.67e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.3e-06	5.6e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	2.28e-06	5.55e-05	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	2.25e-06	5.48e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	2.23e-06	5.43e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	2.22e-06	5.39e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.21e-06	5.37e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—coronary artery disease	2.21e-06	5.37e-05	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	2.2e-06	5.36e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	2.18e-06	5.31e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	2.17e-06	5.28e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	2.17e-06	5.28e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	2.13e-06	5.17e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	2.11e-06	5.13e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AGT—coronary artery disease	2.1e-06	5.1e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	2.06e-06	5.02e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOE—coronary artery disease	2.06e-06	5e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	2.05e-06	4.98e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKT1—coronary artery disease	2.04e-06	4.95e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA1—coronary artery disease	2.03e-06	4.94e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	2e-06	4.87e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	1.89e-06	4.61e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	1.85e-06	4.51e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARG—coronary artery disease	1.79e-06	4.36e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—POMC—coronary artery disease	1.77e-06	4.3e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.74e-06	4.23e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.7e-06	4.15e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	1.7e-06	4.14e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	1.67e-06	4.06e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALB—coronary artery disease	1.61e-06	3.92e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NOS3—coronary artery disease	1.54e-06	3.75e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	1.48e-06	3.6e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	1.45e-06	3.52e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.41e-06	3.43e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—coronary artery disease	1.31e-06	3.19e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—coronary artery disease	1.28e-06	3.12e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	1.21e-06	2.94e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	1.18e-06	2.88e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CA—coronary artery disease	8.67e-07	2.11e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AKT1—coronary artery disease	7.08e-07	1.72e-05	CbGpPWpGaD
